In HD 140Q-KI mice injected with AAV-CasRx/Ctrl gRNA, DEG were enriched in HD-related pathological pathways, and knockdown of HTT mRNA by CRISPR/CasRx effectively alleviated some gene transcription dysregulation related to immune and inflammatory responses and neuronal projection (Fig. 4C). Here, HTT is linked to Huntington disease.